Maricann Group (CNSX:MARI) Price Target Raised to $5.75 at BMO Capital Markets

Maricann Group (CNSX:MARI) had its price objective upped by BMO Capital Markets from $5.50 to $5.75 in a research note issued to investors on Friday morning,BayStreet.CA reports.

Maricann Group Stock Performance

Maricann Group has a 12-month low of $0.87 and a 12-month high of $3.60.

Maricann Group Company Profile

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients.